Yalcin, B. Et Al. 2004. A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study. ANNALS OF ONCOLOGY , vol.15 , 42.

Yalcin, B., ÜNER, A., AKBULUT, H., İÇLİ, F., Buyukcelik, A., Isikdogan, A., ... Dincol, D.(2004). A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study. ANNALS OF ONCOLOGY , vol.15, 42.

Yalcin, Bulent Et Al. "A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study," ANNALS OF ONCOLOGY , vol.15, 42, 2004

Yalcin, Bulent Et Al. "A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study." ANNALS OF ONCOLOGY , vol.15, pp.42, 2004

Yalcin, B. Et Al. (2004) . "A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study." ANNALS OF ONCOLOGY , vol.15, p.42.

@article{article, author={Bulent Yalcin Et Al. }, title={A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study}, journal={ANNALS OF ONCOLOGY}, year=2004, pages={42} }